Funded by: United States Agency for International Development (USAID)
Project Duration: 2010 to present
Countries: Global, Bangladesh, MalawiPartners:
URC is the prime holder of this contract whose other participants are Partners In Health, Jhpiego, Project HOPE, BEA Enterprises, Canadian Lung Association, Clinical and Laboratory Standards Institute, Dartmouth Medical School Section of Infectious Disease and International Health, Euro Health Group, Foundation for Innovative New Diagnostics, Medical Service Corporation International, National Jewish Health, New Jersey Medical School Global Tuberculosis Institute, and the World Health Organization.
** News: URC Posts RFA to support knowledge management and web portal management for TB CARE II project*.
TB CARE II complements existing and planned projects in the Bureau for Global Health to provide global leadership and support to national TB programs (NTPs) and other in-country partners. The project assists these stakeholders to accelerate the implementation of TB DOTS, TB/HIV, and programs for the programmatic management of drug resistant TB. TB CARE II can help countries scale up evidence-based interventions and improve outcomes in TB prevention and control in USAID TB Priority countries. The partnership brings extensive expertise in strengthening TB services, including establishing community-based multi-drug resistant (MDR) TB prevention and treatment strategies. USAID Missions can procure TA and support services from the URC-led TB CARE II partnership through field support mechanisms.
At the global level, TB CARE II is supporting a number of core activities in universal access, the prevention of MDR-TB, infection control, TB/HIV, and health systems strengthening.
For additional information and to access TB CARE II resources, please visit the TB CARE II Website.